{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:05:13Z","timestamp":1789506313067,"version":"build-2803163510"},"reference-count":52,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p>Pemphigus is a life\u2010threatening autoimmune bullous disorder that requires long\u2010term treatment with systemic corticosteroids mostly in conjunction with further immunosuppressants. Rituximab has opened a new avenue for severe and refractory pemphigus patients. In 95% of the 136 pemphigus patients reported to date in the English, French, and German literature, at least a partial remission has been achieved. In about two\u2010thirds of communicated cases, application of rituximab resulted in the healing of all lesions. A controlled prospective study, however, has only recently being initiated. In pemphigus, rituximab is aimed at resetting the immune system to a condition in which autoreactive B lymphocytes are eliminated or sufficiently controlled. Here, we review mechanisms of action, different treatment protocols, clinical responses, and the safety profile of rituximab.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2009.04744.x","type":"journal-article","created":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T22:00:18Z","timestamp":1251842418000},"page":"683-691","source":"Crossref","is-referenced-by-count":95,"title":["Rituximab in Severe Pemphigus"],"prefix":"10.1111","volume":"1173","author":[{"given":"Enno","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Goebeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,9]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra061111"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.07.021"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2008.08.003"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2003.05665.x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890260105016"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1586\/17469872.3.3.259"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-007-0471-x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.11.006"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8021-6"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2006.02151.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2085"},{"key":"e_1_2_8_13_2","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita T.","year":"2008","journal-title":"J. Clin. Invest."},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706383"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032534"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1954"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0424"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2004.04.015"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21617"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20592"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10764"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02720.x"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1639"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.083162"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.126273"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05580.x"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06602.x"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.178"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.172"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067752"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06740.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062930"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05302.x"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08358.x"},{"key":"e_1_2_8_36_2","first-page":"266","article-title":"Delayed response of oral pemphigus vulgaris to rituximab treatment","volume":"16","author":"Niedermeier A.","year":"2006","journal-title":"Eur. J. Dermatol."},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07646.x"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.8.1033"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03423.x"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2008.00194.x"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2007.10.010"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02340.x"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000187431"},{"key":"e_1_2_8_44_2","first-page":"335","article-title":"Rituximab therapy in severe juvenile pemphigus vulgaris","volume":"80","author":"Mamelak A.J.","year":"2007","journal-title":"Cutis."},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-007-1414-x"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.116339"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2008.tb02030.x"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630802032603"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02450.x"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03444.x"},{"key":"e_1_2_8_51_2","first-page":"717","article-title":"Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chroniclymphocytic leukemia","volume":"18","author":"Schierl M.","year":"2008","journal-title":"Eur. J. Dermatol."},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.07.031"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2007.11.013"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2009.04744.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2009.04744.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T07:37:16Z","timestamp":1695627436000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2009.04744.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1749-6632.2009.04744.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04744.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}